Login / Signup

Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification.

Alessandro RabioloKeith BartonAndrew Ian McNaught
Published in: The British journal of ophthalmology (2022)
Keyphrases
  • patient reported outcomes
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label
  • study protocol
  • cataract surgery
  • phase iii